Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

188

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
D05AA	ICHTAMMOL OINTMENT	G	Tars - 10%	10%	Ointment	90,869 L.L
D05AA	ICHTAMMOL OINTMENT	G	Tars - 10%	10%	Ointment	174,060 L.L
G04CA53	VESOMNI	B	Tamsulosin HCl - 0.4mg, Solifenacin succinate - 6mg		Tablet, modified release	4,491,122 L.L
G04CA52	DUTAMSUVITAE	G	Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg		Capsule, hard	2,168,962 L.L
G04CA52	DUTASTERIDE/TAMSULOSINE ARROW	G	Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg		Capsule	1,337,123 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
G04CA02	APO-TAMSULOSIN CR	G	Tamsulosin HCl - 0.4mg	0.4mg	Tablet	607,417 L.L
G04CA02	PROSTAFINE	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	761,511 L.L
G04CA02	TALUSIN	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	683,440 L.L
G04CA02	MINGO	G	Tamsulosin - 0.4mg	0.4mg	Capsule	673,201 L.L
G04CA02	TAMSU GENERICON RETARD	G	Tamsulosin - 0.4mg	0.4mg	Capsule, hard, modified release	615,480 L.L
L02BA01	TAMOXIFEN SANDOZ	G	Tamoxifen (citrate) - 20mg	20mg	Tablet, film coated	497,222 L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 20mg	20mg	Tablet	858,715 L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 10mg	10mg	Tablet	415,247 L.L
L01FX29	TALVEY	B	Talquetamab - 40mg/ml	40mg/ml	Injectable solution	555,916,745 L.L
L01FX29	TALVEY	B	Talquetamab - 2mg/ml	3mg/1.5ml	Injectable solution	45,594,403 L.L
L01XK04	TALZENNA	B	Talazoparib - 1mg	1mg	Capsule	401,512,167 L.L
L01XK04	TALZENNA	B	Talazoparib - 0.25mg	0.25mg	Capsule	133,836,699 L.L
S01EE05	TAFLUPRO	G	Tafluprost - 0.0015%	0.0015%	Solution	1,912,288 L.L
N07XX08	VYNDAMAX	B	Tafamidis - 61mg	61mg	Capsule	784,020,041 L.L
G04BE08	CIALIS	B	Tadalafil - 5mg	5mg	Tablet, film coated	6,512,261 L.L
G04BE08	APO-TADALAFIL	G	Tadalafil - 5mg	5mg	Tablet	1,635,456 L.L
G04BE08	DURALIS 5	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,791,790 L.L
G04BE08	ENKOR	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L
G04BE08	HEROX	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,416,410 L.L
G04BE08	LINK	G	Tadalafil - 5mg	5mg	Tablet, film coated	3,926,708 L.L
G04BE08	RAVANA	G	Tadalafil - 5mg	5mg	Tablet	1,501,264 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 5mg	5mg	Tablet, coated	3,369,013 L.L
G04BE08	TADALAGEN	G	Tadalafil - 5mg	5mg	Tablet, film coated	1,766,193 L.L

...

188